Evidence map›Paper›PMID 37458789›Full record

ArticlePsychopharmacology2023

Smoking reduction using electronic nicotine delivery systems in combination with nicotine skin patches.

Jed E Rose, Suzanne Frisbee, David Campbell, Alfred Salley, Susan Claerhout, James M Davis

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Trial
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jed E RoseDuke Center for Smoking Cessation, Duke University School of Medicine, 2424 Erwin Road, Suite 201, Durham, NC, 27705, USA. jed.rose@duke.edu.ORCID http://orcid.org/0000-0002-4861-7750
Suzanne FrisbeeDuke Center for Smoking Cessation, Duke University School of Medicine, 2424 Erwin Road, Suite 201, Durham, NC, 27705, USA.
David CampbellDuke Center for Smoking Cessation, Duke University School of Medicine, 2424 Erwin Road, Suite 201, Durham, NC, 27705, USA.
Alfred SalleyDuke Center for Smoking Cessation, Duke University School of Medicine, 2424 Erwin Road, Suite 201, Durham, NC, 27705, USA.
Susan ClaerhoutDuke Center for Smoking Cessation, Duke University School of Medicine, 2424 Erwin Road, Suite 201, Durham, NC, 27705, USA.
James M DavisDuke Center for Smoking Cessation, Duke University School of Medicine, 2424 Erwin Road, Suite 201, Durham, NC, 27705, USA.
Duke University · US

Funding

Recruitment CoreP50DA027840 · NIDA · DUKE UNIVERSITY · PI ROSE, JED E · 2010 to 2019
$14.9M
NIDA NIH HHS 5P50DA027840NIDA NIH HHS P50 DA027840
6 · The paper itself

Abstract

rationaleElectronic nicotine delivery systems (ENDS) are used by smokers seeking to reduce combustible cigarette (CC) use, but the role of nicotine replacement vs. behavioral and sensory factors is still poorly understood. We hypothesized that providing nicotine from ENDS in addition to nicotine skin patches would promote smoking reduction relative to non-nicotine control ENDS.

objectivesTo assess the effects on smoking behavior of using nicotine vs. placebo ENDS in smokers using nicotine vs. placebo patches.

methodsNinety-four daily smokers were enrolled in a study that randomly assigned them to receive ENDS with nicotine vs. without nicotine and skin patches with vs. without nicotine. Smoking reduction and cessation were assessed over an 8-week period by self-report and by expired air carbon monoxide (CO) measurements. The primary outcome was defined as reduction in expired air CO.

resultsThe use of nicotine in ENDS led to significant reductions in smoking (ENDS nicotine vs. placebo difference in CO change = -9.2 ppm; 90% CI (-1.5 ppm, -16.9 ppm)) and was highly correlated with reductions in self-reported cigarettes per day (r=0.6). The effect of nicotine in nicotine patches was not statistically significant (patch nicotine vs. placebo difference in CO change = -0.1 ppm; 90% CI (-7.8 ppm, 7.6 ppm)).

conclusionsThe presence of nicotine in ENDS was associated with a large reduction in smoking. Additional studies will be needed to determine whether there may be additive effects of nicotine ENDS and nicotine patches on smoking abstinence.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationSmoking ReductionHumansNicotineTobacco Use Cessation DevicesNicotineCigaretteE-cigaretteElectronic nicotine delivery systemENDSHarm reductionNicotine patchSmokingSmoking cessation

Identifiers

PMID37458789
PMCPMC10471641
OpenAlexW4384525055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.